Medicine (Jun 2022)

Inhaled opioids for cancer pain relief

  • Magdalena Osowicka, MD, PhD,
  • Piotr Janowiak, MD, PhD,
  • Agnieszka Gorzewska, MD, PhD,
  • Monika Lichodziejewska-Niemierko, MD, PhD

DOI
https://doi.org/10.1097/MD.0000000000028921
Journal volume & issue
Vol. 101, no. 25
p. e28921

Abstract

Read online

Abstract. Despite the many new possibilities, cancer pain treatment is not always effective and often poses a challenge for practitioners. At the end-of-life care, both oral and subcutaneous drug delivery very often are not attainable. The increasing number of patients in terminal stage of chronic diseases forced us to look for the alternative ways of administration of pain treatment. In this context, the potentially rapid onset of action and ease of use make aerosolized drug delivery an attractive option in palliative care settings. The objective of this review was to identify literature on pain relief with inhaled opioids. The evidence suggests that nebulized opioids might be effective in the treatment of pain in various aetiologies; however, randomized controlled studies on nebulization therapy for cancer pain are lacking.